Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 2
1987 7
1988 4
1989 7
1990 7
1991 2
1992 1
1993 1
1994 3
1996 8
1997 7
1998 2
1999 5
2000 3
2001 5
2002 7
2003 3
2004 6
2005 6
2006 5
2007 10
2008 3
2009 9
2010 7
2011 8
2012 13
2013 10
2014 9
2015 13
2016 16
2017 25
2018 22
2019 13
2020 6
2021 4
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
de Witte T, Bowen D, Robin M, Malcovati L, Niederwieser D, Yakoub-Agha I, Mufti GJ, Fenaux P, Sanz G, Martino R, Alessandrino EP, Onida F, Symeonidis A, Passweg J, Kobbe G, Ganser A, Platzbecker U, Finke J, van Gelder M, van de Loosdrecht AA, Ljungman P, Stauder R, Volin L, Deeg HJ, Cutler C, Saber W, Champlin R, Giralt S, Anasetti C, Kröger N. de Witte T, et al. Among authors: volin l. Blood. 2017 Mar 30;129(13):1753-1762. doi: 10.1182/blood-2016-06-724500. Epub 2017 Jan 17. Blood. 2017. PMID: 28096091 Free PMC article. Review.
Heme therapy.
Mustajoki P, Tenhunen R, Tokola O, Volin L. Mustajoki P, et al. Among authors: volin l. Am J Med. 1989 Apr;86(4):509-10. doi: 10.1016/0002-9343(89)90368-9. Am J Med. 1989. PMID: 2929648 No abstract available.
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma.
Luoma S, Silvennoinen R, Rauhala A, Niittyvuopio R, Martelin E, Lindström V, Heiskanen J, Volin L, Ruutu T, Nihtinen A. Luoma S, et al. Among authors: volin l. Ann Hematol. 2021 Jun;100(6):1553-1567. doi: 10.1007/s00277-021-04514-y. Epub 2021 Apr 17. Ann Hematol. 2021. PMID: 33866396 Free PMC article.
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis.
Robin M, de Wreede LC, Wolschke C, Schetelig J, Eikema DJ, Van Lint MT, Knelange NS, Beelen D, Brecht A, Niederwieser D, Vitek A, Bethge W, Arnold R, Finke J, Volin L, Yakoub-Agha I, Nagler A, Poiré X, Einsele H, Chevallier P, Holler E, Ljungman P, Robinson S, Radujkovic A, McLornan D, Chalandon Y, Kröger N. Robin M, et al. Among authors: volin l. Haematologica. 2019 Sep;104(9):1782-1788. doi: 10.3324/haematol.2018.205211. Epub 2019 Feb 7. Haematologica. 2019. PMID: 30733269 Free PMC article.
Heme arginate: effects on hemostasis.
Volin L, Rasi V, Vahtera E, Tenhunen R. Volin L, et al. Blood. 1988 Mar;71(3):625-8. Blood. 1988. PMID: 3345341 Free article.
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Kolonen A, Sinisalo M, Huhtala H, Rimpiläinen J, Rintala H, Sankelo M, Koivunen E, Silvennoinen R, Räty R, Ruutu T, Volin L, Porkka K, Jantunen E, Nousiainen T, Kuittinen T, Penttilä K, Pyörälä M, Säily M, Koistinen P, Kauppila M, Itälä-Remes M, Ollikainen H, Rauhala A, Kairisto V, Pelliniemi TT, Elonen E; Finnish Leukemia Group. Kolonen A, et al. Among authors: volin l. Eur J Haematol. 2022 Sep;109(3):257-270. doi: 10.1111/ejh.13805. Epub 2022 Jun 14. Eur J Haematol. 2022. PMID: 35634931 Clinical Trial.
230 results